FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities
暂无分享,去创建一个
S. Spiegl-Kreinecker | T. Mohr | J. Pichler | W. Berger | C. Marosi | R. Silye | B. Grasl-Kraupp | M. Grusch | B. Marian | J. Fischer | T. Czech | M. Micksche | J Fischer | T Czech | K. Holzmann | B Grasl-Kraupp | C Marosi | M Micksche | M Grusch | B Marian | S Allerstorfer | G Sonvilla | H Fischer | S Spiegl-Kreinecker | C Gauglhofer | U Setinek | J Buchroithner | J Pichler | R Silye | T Mohr | K Holzmann | W Berger | U. Setinek | S. Allerstorfer | G. Sonvilla | H. Fischer | C. Gauglhofer | J. Buchroithner | Hendrik Fischer | Sigrid Allerstorfer | Christine Gauglhofer | Rene Silye
[1] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[2] M. Goldfarb,et al. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors , 1988, Molecular and cellular biology.
[3] M. Goldfarb,et al. Expression of the murine fibroblast growth factor 5 gene in the adult central nervous system. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Hardin,et al. Biosynthesis of human fibroblast growth factor-5 , 1991, Molecular and cellular biology.
[5] M. Goldfarb,et al. Expression of the fibroblast growth factor-5 gene in the mouse embryo. , 1991, Development.
[6] C. Cotman,et al. Distribution of fibroblast growth factor 5 mRNA in the rat brain: an in situ hybridization study , 1993, Brain Research.
[7] H. Thoenen,et al. Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons , 1993, Neuron.
[8] R. Bjerkvig,et al. Effects of EGF, BFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain‐tumour biopsies In Vitro , 1993, International journal of cancer.
[9] G. Martin,et al. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations , 1994, Cell.
[10] E. Castrén,et al. Fibroblast Growth Factor‐5 Promotes Differentiation of Cultured Rat Septal Cholinergic and Raphe Serotonergic Neurons: Comparison with the Effects of Neurotrophins , 1994, The European journal of neuroscience.
[11] J. Bruner,et al. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. , 1994, Cancer research.
[12] C. MacArthur,et al. Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.
[13] P. Maher,et al. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. , 1996, Brain research. Molecular brain research.
[14] J. Smith,et al. Fibroblast growth factors and their receptors. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[15] S. Coons,et al. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells , 1997, Oncogene.
[16] J. Sundberg,et al. Angora Mouse Mutation: Altered Hair Cycle, Follicular Dystrophy, Phenotypic Maintenance of Skin Grafts, and Changes in Keratin Expression , 1997, Veterinary pathology.
[17] M. Korc,et al. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions , 1997, Oncogene.
[18] R. Panek,et al. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. , 1998, The Journal of pharmacology and experimental therapeutics.
[19] M. Kan,et al. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. , 1998, Progress in nucleic acid research and molecular biology.
[20] G. Mills,et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. , 1998, Cancer research.
[21] A. Komi,et al. An Alternatively Spliced Fibroblast Growth Factor (FGF)-5 mRNA Is Abundant in Brain and Translates into a Partial Agonist/Antagonist for FGF-5 Neurotrophic Activity* , 1998, The Journal of Biological Chemistry.
[22] J. Hanfelt,et al. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells. , 1998, Cancer research.
[23] T. Imamura,et al. Localization of rat FGF-5 protein in skin macrophage-like cells and FGF-5S protein in hair follicle: possible involvement of two Fgf-5 gene products in hair growth cycle regulation. , 1998, The Journal of investigative dermatology.
[24] C. Raffel. Expression and Growth Stimulatory Effect of Fibroblast Growth Factor 9 in Human Brain Tumors , 1998 .
[25] R. Jensen,et al. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. , 1998, Surgical neurology.
[26] T. Mohr,et al. Evidence for a role of FGF‐2 and FGF receptors in the proliferation of non‐small cell lung cancer cells , 1999, International journal of cancer.
[27] T. Imamura,et al. Dual-mode regulation of hair growth cycle by two Fgf-5 gene products. , 2000, The Journal of investigative dermatology.
[28] K. Unsicker,et al. Fibroblast growth factors‐5 and ‐9 distinctly regulate expression and function of the gap junction protein connexin43 in cultured astroglial cells from different brain regions , 2000, Glia.
[29] G. Christofori,et al. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling , 2001, Nature Cell Biology.
[30] Murray Korc,et al. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells , 2001, International journal of gastrointestinal cancer.
[31] J. Yang,et al. Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. , 2001, Cancer research.
[32] Koshi Matsumoto,et al. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas , 2002, Neurological research.
[33] P. Rathjen,et al. Transient pluripotent cell populations during primitive ectoderm formation: correlation of in vivo and in vitro pluripotent cell development. , 2002, Journal of cell science.
[34] K. Unsicker,et al. Functions of Fibroblast Growth Factor (FGF)-2 and FGF-5 in Astroglial Differentiation and Blood-Brain Barrier Permeability: Evidence from Mouse Mutants , 2003, The Journal of Neuroscience.
[35] Souichi Yoshida,et al. Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. , 2003, The Journal of clinical endocrinology and metabolism.
[36] Bernhard Reuss,et al. Fibroblast growth factors and their receptors in the central nervous system , 2003, Cell and Tissue Research.
[37] W. Berger,et al. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications , 2005, Journal of Cancer Research and Clinical Oncology.
[38] William Pao,et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] V. P. Eswarakumar,et al. Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.
[40] A. Kyritsis,et al. Mechanisms of angiogenesis in gliomas , 2006, Journal of Neuro-Oncology.
[41] C. Dickson,et al. Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.
[42] M. Berger,et al. Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas , 1994, Journal of Neuro-Oncology.
[43] A. Gressner,et al. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells , 2005, Growth factors.
[44] Petra Heffeter,et al. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24). , 2006, Biochemical pharmacology.
[45] C. Pirker,et al. The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals , 2006, Journal of Cell Science.
[46] C. Pirker,et al. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. , 2006, Journal of cell science.
[47] H. Bergmeister,et al. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. , 2006, Cancer research.
[48] A. Paetau,et al. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in Gliomas , 2006, Molecular Cancer Research.
[49] Gerhard Dürnberger,et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. , 2007, Blood.
[50] S. Spiegl-Kreinecker,et al. Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma , 2007, British Journal of Cancer.